anmelden
FTSE All-Share
5.842,37
PKT
+16,28
PKT
+0,28
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 21.05.14 | BP Neutral | Citigroup Corp. | |
| 21.05.14 | Shell (ex Royal Dutch Shell) Neutral | Citigroup Corp. | |
| 21.05.14 | Vodafone Group Neutral | Goldman Sachs Group Inc. | |
| 21.05.14 | Vodafone Group buy | UBS AG | |
| 21.05.14 | AstraZeneca buy | UBS AG | |
| 21.05.14 | AstraZeneca Equal weight | Barclays Capital | |
| 21.05.14 | Vodafone Group overweight | JP Morgan Chase & Co. | |
| 20.05.14 | AstraZeneca Halten | Independent Research GmbH | |
| 20.05.14 | Lloyds Banking Group buy | Deutsche Bank AG | |
| 20.05.14 | Glencore Neutral | UBS AG | |
| 20.05.14 | Rio Tinto buy | UBS AG | |
| 20.05.14 | Standard Chartered buy | Citigroup Corp. | |
| 20.05.14 | AstraZeneca buy | Citigroup Corp. | |
| 20.05.14 | Sky Strong Sell | S&P Capital IQ | |
| 19.05.14 | AstraZeneca buy | Citigroup Corp. | |
| 19.05.14 | AstraZeneca Hold | S&P Capital IQ | |
| 19.05.14 | Diageo buy | Citigroup Corp. | |
| 19.05.14 | Rio Tinto overweight | JP Morgan Chase & Co. | |
| 19.05.14 | Shell (ex Royal Dutch Shell) Equal-Weight | Morgan Stanley | |
| 19.05.14 | Shell (ex Royal Dutch Shell) Neutral | UBS AG | |
| 19.05.14 | Diageo buy | Deutsche Bank AG | |
| 19.05.14 | BP Neutral | UBS AG | |
| 16.05.14 | Lloyds Banking Group Halten | Independent Research GmbH | |
| 16.05.14 | London Stock Exchange (LSE) Neutral | UBS AG | |
| 16.05.14 | London Stock Exchange (LSE) Neutral | JP Morgan Chase & Co. | |
| 16.05.14 | GSK Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 15.05.14 | Rio Tinto buy | UBS AG | |
| 15.05.14 | GSK overweight | Morgan Stanley | |
| 15.05.14 | Barclays kaufen | Independent Research GmbH | |
| 15.05.14 | Shell (ex Royal Dutch Shell) Neutral | JP Morgan Chase & Co. | |
| 15.05.14 | GSK Hold | Deutsche Bank AG | |
| 15.05.14 | AstraZeneca Hold | Deutsche Bank AG | |
| 15.05.14 | Vodafone Group buy | UBS AG | |
| 15.05.14 | Vodafone Group Neutral | Goldman Sachs Group Inc. | |
| 14.05.14 | GSK Neutral | Goldman Sachs Group Inc. | |
| 14.05.14 | Standard Chartered neutral | Deutsche Bank AG | |
| 14.05.14 | London Stock Exchange (LSE) Neutral | UBS AG | |
| 14.05.14 | HSBC Underperform | Credit Suisse Group | |
| 13.05.14 | Vodafone Group overweight | Morgan Stanley | |
| 13.05.14 | Sky buy | Goldman Sachs Group Inc. |
